Full Press Release Details
PHILADELPHIA, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced four poster presentations highlighting its development program for Pompe disease will be included at the 27th International Hybrid Annual Congress of the World Muscle Society, being held October 11-15, 2022 both virtually and in Halifax, Canada.
Poster Presentations:
Abstract Title: Long-term follow-up of cipaglucosidase alfa/miglustat in ambulatory patients with Pompe disease: an open-label phase I/II study (ATB200-02) (Poster #FP.17)
Presenter: Benedikt Schoser, MD, Department of Neurology, Ludwig-Maximilians-University of Munich, Munich, Germany
Flash Poster Presentation: Metabolic Myopathies – Wednesday, October 12, 4:05-4:10 p.m. ADT Location: Ballroom Salon
Poster Session: Metabolic Myopathies – Wednesday, October 12, 4:00-5:30 p.m. ADT Location: Ballroom B1-B2
Abstract Title: Living with Pompe disease in the UK: characterising the patient journey; burden on physical and emotional quality of life; and impact of COVID-19 (Poster #VP.32)
Presenter: Allan Muir, Chair of the Board of Trustees, Pompe Support Network, Petersfield, U.K.
Poster Session: Metabolic Myopathies – Wednesday, October 12, 4:00-5:30 p.m. ADT
Location: Virtual Platform
Abstract Title: Quantification of the burden, unmet needs, management, and COVID‑19 impact of living with Pompe disease in the UK: results of an online patient survey (Poster #VP.33)
Presenter: Val Buxton, Association for Glycogen Storage Disease (UK), Oldbury, U.K.
Poster Session: Metabolic Myopathies – Wednesday, October 12, 4:00-5:30 p.m. ADT
Location: Virtual Platform
Abstract Title: Indirect treatment comparison of three enzyme replacement treatments for late-onset Pompe disease: a network meta-analysis with patient-level and aggregate data (Poster #LSVP.19)
Presenter: Jeff Castelli, PhD, Amicus Therapeutics Inc., Philadelphia, PA, U.S.A.
Poster Session: Poster Session 4 – Friday, October 14, 5:00-6:00 p.m. ADT
Location: Virtual Platform
The posters will be made available on the Amicus website following their respective presentations at the congress.
For more information on the World Muscle Society 2022 Annual Congress, please visit www.wms2022.com.
About Amicus Therapeutics
Executive Director, Investor Relations
Head of Global Corporate Communications